<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kappler M</submitter><funding>Wilhelm Sander-Stiftung</funding><pagination>6-11</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5833914</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5</volume><pubmed_abstract>&lt;h4>Background and purpose&lt;/h4>Hypoxia gene expression signatures are of high prognostic value for head and neck cancer patients. Recently, the prognostic information of a multiple-gene hypoxia signature was found to be provided by the mRNA level of &lt;i>P4HA1&lt;/i> alone (Tawk et al., 2016). Therefore, we studied the prognostic value of &lt;i>P4HA1&lt;/i> in an independent cohort of oral squamous cell carcinoma (OSCC) patients.&lt;h4>Material and methods&lt;/h4>Frozen tumor samples of 118 adult OSCC patients were analysed for &lt;i>P4HA1&lt;/i> mRNA level by quantitative real-time TaqMan™ PCR analysis. Kaplan-Meier analysis and Cox's regression analysis were performed to characterize the prognostic impact of &lt;i>P4HA1&lt;/i> mRNA level in OSCC patients.&lt;h4>Results&lt;/h4>The analyzed patient cohort was divided into f</pubmed_abstract><journal>Clinical and translational radiation oncology</journal><pubmed_title>P4HA1: A single-gene surrogate of hypoxia signatures in oral squamous cell carcinoma patients.</pubmed_title><pmcid>PMC5833914</pmcid><funding_grant_id>FKZ: 2013.090.1</funding_grant_id><pubmed_authors>Bethmann D</pubmed_authors><pubmed_authors>Gallwitz L</pubmed_authors><pubmed_authors>Guttler A</pubmed_authors><pubmed_authors>Kessler J</pubmed_authors><pubmed_authors>Kappler M</pubmed_authors><pubmed_authors>Horter S</pubmed_authors><pubmed_authors>Taubert H</pubmed_authors><pubmed_authors>Eckert AW</pubmed_authors><pubmed_authors>Bache M</pubmed_authors><pubmed_authors>Kaune T</pubmed_authors><pubmed_authors>Kotrba J</pubmed_authors><pubmed_authors>Vordermark D</pubmed_authors><pubmed_authors>Bilkenroth U</pubmed_authors><pubmed_authors>Greither T</pubmed_authors><pubmed_authors>Rot S</pubmed_authors><pubmed_authors>Wichmann H</pubmed_authors></additional><is_claimable>false</is_claimable><name>P4HA1: A single-gene surrogate of hypoxia signatures in oral squamous cell carcinoma patients.</name><description>&lt;h4>Background and purpose&lt;/h4>Hypoxia gene expression signatures are of high prognostic value for head and neck cancer patients. Recently, the prognostic information of a multiple-gene hypoxia signature was found to be provided by the mRNA level of &lt;i>P4HA1&lt;/i> alone (Tawk et al., 2016). Therefore, we studied the prognostic value of &lt;i>P4HA1&lt;/i> in an independent cohort of oral squamous cell carcinoma (OSCC) patients.&lt;h4>Material and methods&lt;/h4>Frozen tumor samples of 118 adult OSCC patients were analysed for &lt;i>P4HA1&lt;/i> mRNA level by quantitative real-time TaqMan™ PCR analysis. Kaplan-Meier analysis and Cox's regression analysis were performed to characterize the prognostic impact of &lt;i>P4HA1&lt;/i> mRNA level in OSCC patients.&lt;h4>Results&lt;/h4>The analyzed patient cohort was divided into f</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Aug</publication><modification>2025-04-19T15:18:05.371Z</modification><creation>2019-03-26T23:22:37Z</creation></dates><accession>S-EPMC5833914</accession><cross_references><pubmed>29594211</pubmed><doi>10.1016/j.ctro.2017.05.002</doi></cross_references></HashMap>